MMP2 and urinary bladder carcinoma: TRPV2 activation was also shown to promote bladder cancer cell metastasis via either matrix metalloproteinase-2- (MMP-2-) [58] or adrenomedullin-dependent [59] mechanisms in the human bladder carcinoma cell line T24/83.